Synthetic Intermediates for Deuterated Pharmaceuticals

CIL’s stable isotope resources have allowed us to increase our capabilities in the manufacturing 
of deuterated and 13C-labeled APIs, from early development phase to full-scale production needs (milligram to multi-kilogram/ton quantities). Many of these intermediates are available from stock. 
CIL has more than 15,000 products and ISO 13485 quality systems, and our custom synthesis expertise 
for incorporating 13C, 2H (deuterium), 15N, 17O, and/or 18O into your compound is unsurpassed.
Our business is stable isotopes, but our focus is you, the customer. We would greatly appreciate 
an opportunity to partner with you on your next project. 
Application | Cambridge Isotope Laboratories, Inc.